Thor Medical ASA (OSL: TRMED)

Norway flag Norway · Delayed Price · Currency is NOK
2.650
+0.055 (2.12%)
Jan 17, 2025, 4:28 PM CET
124.58%
Market Cap 639.99M
Revenue (ttm) n/a
Net Income (ttm) -13.06M
Shares Out 234.86M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,603,860
Average Volume 3,374,877
Open 2.620
Previous Close 2.595
Day's Range 2.550 - 2.650
52-Week Range 0.850 - 4.995
Beta n/a
RSI 50.60
Earnings Date Feb 26, 2025

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was founded in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 2
Stock Exchange Oslo Børs
Ticker Symbol TRMED
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.